The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

AACR to Honor Leading Researchers at Breast Cancer Symposium

October 12, 2010 1:31 pm | by AACR | News | Comments

PHILADELPHIA —The 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers during its meeting, which will be held Dec. 8-12 in the Henry B. Gonzales Convention Center, San Antonio, Texas. Klaus Pantel, M.D., Ph.D., is the recipient of the...


Mayo Clinic researcher inducted into the Institute of Medicine

October 12, 2010 12:32 pm | by EurekAlert | News | Comments

(Mayo Clinic) Mayo Clinic radiologist and researcher Richard Ehman, M.D., has been named by the National Academy of Sciences to the Institute of Medicine. Selection to the Institute is one of the highest honors in medicine in the United States.


Traditional health practices popular among older people who choose not to have flu vaccine

October 12, 2010 11:34 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Eating steamed pears and being rubbed with a coin are just some of more unusual indigenous health practices used by older people worldwide to ward off, or treat, influenza. Nurse researchers studied nine countries with different health care systems: the UK,...


Factors Beyond Crowding Affect Molecular Motion in Cells

October 12, 2010 11:33 am | by Georgia Tech Institute of Technology | News | Comments

Using large-scale computer simulations, researchers at the Georgia Institute of Technology have identified the most important factors affecting how molecules move through the crowded environment inside living cells.

Elsevier announces publishing of the Journal of Molecular Diagnostics

October 12, 2010 11:32 am | by EurekAlert | News | Comments

(Elsevier) Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish the Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular...


Capturing all your money matters. Here’s how

October 12, 2010 11:32 am | by Diagnostic Imaging | News | Comments

In my last report (Capturing all your money matters. Here’s why) I explained why it matters to capture as much revenue as possible. Let’s recap some of the major reasons for doing this.


New Institute Paves Way for Rapid Cancer Drug Development

October 12, 2010 11:31 am | by Bio-Medicine.Org | News | Comments

GREENVILLE, S.C., Oct. 12 /PRNewswire-USNewswire/ -- Greenville Hospital System University Medical Center (GHS) unveiled details of its new Institute for Translational Oncology Research, a visionary cancer initiative that will help pave the way for new breakthroughs in rapid drug...


Long-lasting mechanical heart implanted for the first time in Canada in heart-failure patient

October 12, 2010 10:33 am | by EurekAlert | News | Comments

(University Health Network) In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure. The new device is longer lasting than older generation LVADs and may eliminate the need for a...


MLSC begins fall Accelerator Loan Program

October 12, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The Massachusetts Life Sciences Center has launched its Fall 2010 Accelerator Loan Program for early-stage life sciences companies, with $3.8 million available this fall for loans capped at a maximum of $750,000 per company.

ArQule expands partnership with Japanese pharma

October 12, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

ArQule Inc. has announced it is expanding its oncology research, development and license agreement with Japanese pharmaceutical company Daiichi Sankyo, growing the number of therapeutic targets under development and extending the deal for two years.

Ocular Therapeutix completes eye drug delivery study

October 12, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ocular Therapeutix Inc., a Bedford developer of ophthalmic therapeutic products, has closed a Proof of Principle clinical study of its moxifloxacin punctum plug, a sustained drug delivery device for post-cataract surgery.

First phase II trial of heart disease treatment for Duchenne muscular dystrophy launched

October 12, 2010 10:31 am | by EurekAlert | News | Comments

(Kennedy Krieger Institute) Kennedy Krieger announced the launch of a first-of-its-kind phase II clinical trial to investigate a treatment for heart disease in Duchenne muscular dystrophy (DMD). Made possible by a $545,000 grant from Pilot Trials Now, a DMD initiative of Charley's Fund...


Class I Medical Device Recall: Multi-Med, Inc. Huber (Non-coring) Needles and Finished Devices Containing Huber Needles Labeled as "All-Med Medical Products, Inc." and "Marque...

October 12, 2010 9:34 am | by U.S. Food & Drug Administration | News | Comments

Huber needles are safety needles used on vascular access ports implanted in patients in need of repeated intravenous therapy. A "coring" Huber needle could damage the implanted port by removing silicone slivers from the access membrane. The defect in the

Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call

October 12, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Oct. 12 /- Express Scripts (Nasdaq: ESRX ), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its third quarter earnings and 2011 earnings guidance on Wednesday, October 27, 2010 after the market closes and will...


Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.

October 12, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Oct. 12 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has announced a definitive agreement to end its non-exclusive distribution arrangement in the United...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.